Virtual and biomolecular screening converge on a selective agonist for GPR30

Nature Chemical Biology
Cristian G BologaEric R Prossnitz

Abstract

Estrogen is a hormone critical in the development, normal physiology and pathophysiology of numerous human tissues. The effects of estrogen have traditionally been solely ascribed to estrogen receptor alpha (ERalpha) and more recently ERbeta, members of the soluble, nuclear ligand-activated family of transcription factors. We have recently shown that the seven-transmembrane G protein-coupled receptor GPR30 binds estrogen with high affinity and resides in the endoplasmic reticulum, where it activates multiple intracellular signaling pathways. To differentiate between the functions of ERalpha or ERbeta and GPR30, we used a combination of virtual and biomolecular screening to isolate compounds that selectively bind to GPR30. Here we describe the identification of the first GPR30-specific agonist, G-1 (1), capable of activating GPR30 in a complex environment of classical and new estrogen receptors. The development of compounds specific to estrogen receptor family members provides the opportunity to increase our understanding of these receptors and their contribution to estrogen biology.

References

Aug 12, 1998·The Journal of Steroid Biochemistry and Molecular Biology·H RochefortM Garcia
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Jul 19, 2001·The Journal of Biological Chemistry·J M HallK S Korach
Mar 28, 2002·Science's STKE : Signal Transduction Knowledge Environment·Tamas Balla, Péter Várnai
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rebecca L RichDavid G Myszka
Nov 26, 2002·Journal of Chemical Information and Computer Sciences·Joseph L DurantJames G Nourse
Apr 18, 2003·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Sergio RamirezBruce S Edwards
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Kenneth S KorachJohn F Couse
Aug 4, 2004·Current Opinion in Chemical Biology·Tudor I Oprea, Hans Matter
Aug 4, 2004·Current Opinion in Chemical Biology·Bruce S EdwardsLarry A Sklar
Nov 9, 2004·Trends in Pharmacological Sciences·Anna WallerLarry A Sklar
Feb 12, 2005·Science·Chetana M RevankarEric R Prossnitz
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Kent Osborne, Rachel Schiff
Apr 19, 2005·Endocrinology·Joseph P McGillis
Feb 14, 2006·Current Drug Discovery Technologies·Marius M OlahTudor I Oprea

❮ Previous
Next ❯

Citations

Jun 13, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Young Mi SeokIn Kyeom Kim
Nov 11, 2009·Breast Cancer Research and Treatment·Hugo Arias-PulidoMassimo Cristofanilli
Nov 17, 2007·Journal of Computer-aided Molecular Design·Dimitar P HristozovJohann Gasteiger
Oct 21, 2010·Endocrine·Dengfeng WangChen Chen
Aug 27, 2011·Journal of Chemical Information and Modeling·Marijn P A SandersJan P G Klomp
Mar 1, 2012·Journal of Chemical Information and Modeling·Tammy BiniashviliYossef Kliger
Aug 13, 2011·Chemical Reviews·Vellaisamy SridharanJ Carlos Menéndez
May 16, 2013·Journal of Medicinal Chemistry·Donna M HurynPeter Wipf
Jan 1, 2010·Journal of Medicinal Chemistry·Chinnasamy RameshJeffrey B Arterburn
Feb 1, 2012·Behavioral Neuroscience·Bruce S McEwenElizabeth M Waters
May 12, 2009·Nature Chemical Biology·Megan K DennisEric R Prossnitz
Jun 30, 2009·Nature Chemical Biology·Steffen RennerHerbert Waldmann
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Eunah ChungJoan V Ruderman
Jan 30, 2010·The Journal of Biological Chemistry·Kazuaki TakabeSarah Spiegel
Apr 16, 2011·The Journal of Biological Chemistry·Natasha C Lucki, Marion B Sewer
May 31, 2012·The Journal of Biological Chemistry·Eunsook LeeMichael Aschner
Sep 2, 2010·Assay and Drug Development Technologies·Larry Sklar, Bruce Edwards
Jun 19, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 11, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·B Sumith Jayasinghe, David C Volz
Feb 18, 2011·Journal of Cardiovascular Pharmacology·Sarah H LindseyMark C Chappell
Jun 8, 2011·Clinical and Experimental Pharmacology & Physiology·Shui-Bing LiuMing-Gao Zhao
Feb 18, 2009·Cephalalgia : an International Journal of Headache·C S LivermanN E J Berman
Feb 15, 2008·Annual Review of Physiology·Eric R ProssnitzHelen J Hathaway
Aug 26, 2011·American Journal of Physiology. Cell Physiology·Andrei A TicaEugen Brailoiu
Sep 1, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Anne M Deschamps, Elizabeth Murphy
Nov 3, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Jean Chrisostome BopassaEnrico Stefani
Jan 31, 2009·Circulation Research·Elvira HaasMatthias Barton

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.